Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Heads Should Roll
View:
Post by Gorf79 on Apr 05, 2022 9:47pm

Heads Should Roll

I’m a first time poster but a long, long suffering investor and I am infuriated by today’s complete disregard for shareholder’s investment position.

Whoever decided to put out a release that was essentially positive, but due to its incomprehensible presentation, led to a30% loss in market capitalization should be immediately fired. Walked out the door fired! A 30% loss on good news!

Would a summary be too much to ask for?

How does an operation that releases so little of value to their shareholders manage to put so little effort and enthusiasm into their news releases when they do have something to say?

A 30% loss on good news!
Comment by ScienceFirst on Apr 05, 2022 9:55pm
Gorf79  ... Samething happened on this Nov. 8, 2017.  The  stock price dropped from 0.41$ to 0.17$, for no justified reason, on excellent and easy to decipher news, especially that we now know that the Ph. 1b was terminated early later on because of outstanding data (p#5 and p#6 having been cancer free with only 1 dose). So the current drop has no more justification and it will re ...more  
Comment by enriquesuave on Apr 05, 2022 10:16pm
"Conclusion: Study II has delivered significant clinical results to date for the primary, secondary and tertiary objectives." Hopefully what the FDA wants to see for BTD. Novelty of a One-and-Done single treatment with high efficacy and safe.  I think I understand what they mean here "The Study II optimized treatment patients, who received either an optimized primary ...more  
Comment by CancerSlayer on Apr 06, 2022 12:24am
  Agree....re: the "optimized'" data (collected post August 1, 2020), the 23 patients reported at 90 days appear to include only those who received an optimized "primary" treatment, & they would be getting a subsequent optimized maintenance treatment at 6 months.  Looking at all Ph 1b & Ph 2 patients, there are a total of 38 patients.  For Ph 2 ...more  
Comment by CancerSlayer on Apr 06, 2022 1:05am
Comment by fredgoodwinson on Apr 06, 2022 2:26am
Thanks Gorf. You have managed to say in a short post what I was trying (and failing) to get across in 3 longer ones. This is that apart from maintaining an increasingly longer silence on every other massive potential positive about this Company Management have yet again couched a technical announcement in such a way as to make positive news look much less so to the uninitiated and difficult to ...more  
Comment by Oilminerdeluxe on Apr 06, 2022 2:53am
This company will make me into a nutter one of these days. I suspect they didn't want to write a pr that is easy to understand. But on the other hand, I can't imagine results being any less next time they update. Which should mean things ARE looking very good. But I am just a simpleton on the other hand. Some more discussions about the data from the team would be welcome next time they ...more  
Comment by stocksnbonds458 on Apr 05, 2022 10:28pm
Golf, you are 100% correct. I don't think Mandel gives a rats azz about the investors, else he wouldn't consistently dress up good news and present it as confusing muddled garbage.
Comment by FGPstock on Apr 05, 2022 10:29pm
#FINANANCING. look at 2019, TLT did the same thing. not the way to raise money. Results were great, management still can't seem to put things together... I expect it to play out the same way they did last time. There is no way we should have the same valuation as 2019, but here we are...
Comment by socksnblonds642 on Apr 05, 2022 10:43pm
We are fodder. Simple. To be used and abused accordingly. As required. Hopefully we ride this wave and make some money This could be a play. There was no need to make this news release in this way so there must be an underlying reason that we don't understand yet. We will know soon though imo   Hopefully to do with BTD and not a PP. Maybe the market reacted the way the company wanted it ...more  
Comment by Rumpl3StiltSkin on Apr 05, 2022 11:08pm
This NR today has nothing to do with the companies financial position. You know this yet still put this out there, why?? Troll?!?!?
Comment by valueman1 on Apr 05, 2022 10:33pm
Absolutely nailed it! As a long time believer in the technology of the company I wholeheartedly agree. Management has let us down time and time again. An easily readable and understandable news release should be a no brainer. However, this team can't seem to understand that the numbers need to be easily understood by investors   Once again love the technology, management not so much
Comment by stocksnbonds458 on Apr 05, 2022 10:37pm
I think it comes down to a lack of respect, we are looked at as fodder and treated as such. I suspect it's intentional, but am unclear of the motive. What's the benefit for them to keep the share price down?
Comment by Gorf79 on Apr 05, 2022 10:43pm
When you, as an intelligent investor, read a news release over your morning coffee and you cannot discern whether stock will close up 50%, down 30% or flat on the day there is a problem. This release just screams apathy towards all shareholders by management.  Shareholders were and are better off hearing nothing until they make an effort vis a vis their shareholder base and hire someone ...more  
Comment by CatoCan on Apr 05, 2022 11:13pm
What the heck. Haven't heard about this company before but saw this post and took a look. I don't see how the press release released today could cause such a dip. It has been a long time since I was in a science class but the results seem postive for the treatment. Why would the stock dip?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250